Concepedia
Statistics
Publications
70
Citations
2.7K
H-Index
33
Active since
1987
Affiliations
Drug Discovery Laboratory (Norway)(Current)
Discovery Laboratories (United States)
Osaka Medical and Pharmaceutical University
The University of Tokyo
Astellas Pharma (Japan)
Koji Nagai is an author at Drug Discovery Laboratory (Norway) specializing in life sciences, drug discovery, and microbiology.
Publications per year
1987–2025
Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-
Kosuke Ebina, Motomu Hashimoto, Wataru Yamamoto et al. · PLoS ONE · 2018 · 122 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
YM-254890, a Novel Platelet Aggregation Inhibitor Produced by Chromobacterium sp. QS3666
Masatoshi Taniguchi, Koji Nagai, Nakako Arao et al. · The Journal of Antibiotics · 2003 · 110 citations · Full text
Medicine, Hematology, Pharmacology +9
Azumamides A–E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge <i>Mycale izuensis</i>
Yoichi Nakao, Satoru Yoshida, Shigeki Matsunaga et al. · Angewandte Chemie International Edition · 2006 · 104 citations
Natural Sciences, Marine Biology, Medicinal Chemistry +15
Carteramine A, an inhibitor of neutrophil chemotaxis, from the marine sponge Stylissa carteri
Hirotsugu Kobayashi, Koki Kitamura, Koji Nagai et al. · Tetrahedron Letters · 2007 · 102 citations
Natural Sciences, Marine Biology, Marine Sciences +12
Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp.
Yuhta Masuoka, Atsuko Nagai, Kazuo Shin‐ya et al. · Tetrahedron Letters · 2001 · 100 citations
Life Sciences, Biotechnology, Microbiology +7
1–5 of 70